Primary information |
---|
sequence ID | Seq_8281 |
Peptide sequence | THRIHWESASLLR |
CancerPDF_ID | CancerPDF_ID929, CancerPDF_ID9472, |
PMID | 19795908,26379225 |
Protein Name | Complement C3,Complement C3 |
UniprotKB Entry Name | CO3_HUMAN,CO3_HUMAN |
Fluid | Plasma,Plasma |
M/Z | 535.95,1605.87 |
Charge | 3,NA |
Mass (in Da) | NA,NA |
fdr | NA,NA |
Profiling Technique | LC-MS,MALDI-TOF |
Peptide Identification technique | MALDI-TOF/TOF,MALDI-TOF/TOF |
Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
Labelled/Label Free | Labelled,Label Free |
FDR | less than 7%,NA |
CancerPDF_ID | CancerPDF_ID929, CancerPDF_ID9472, |
p-Value | NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT (v 2.3) |
Length | 13,13 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer |
Database | NCBI refseq Protein Database,UniprotKB |
Modification | NA,NA |
Number of Patients | "42 normal, 28 patients","94 patients with CRC, 23 with liver metastasis from CRC (histologically defined) and 34 subjects, which underwent colonoscopy and resulted negative" |
Regulation | NA,Lower intensity in liver metastasis than control groups and an opposite trend in adenoma and CRC group. |
Validation | NA,NA |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | NA |
IEDB | 533899
|